{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T16:28:18Z","timestamp":1794414498315,"version":"4.9.1"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"16","license":[{"start":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T00:00:00Z","timestamp":1789084800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T00:00:00Z","timestamp":1789084800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000002","name":"U.S. Department of Health & Human Services | National Institutes of Health","doi-asserted-by":"publisher","award":["P30-EY01583\u201326"],"award-info":[{"award-number":["P30-EY01583\u201326"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001818","name":"Research to Prevent Blindness","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001818","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eye"],"published-print":{"date-parts":[[2026,11]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To evaluate the incidence and baseline predictors of participant discontinuation in Diabetic Retinopathy Clinical Research Retina Network (DRCRnet) studies<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Using the publicly available DRCRnet data, discontinuation rate and its 95% confidence intervals (95% CI) were calculated. Univariable and multivariable logistic regression models were used to assess predictors for participant discontinuation, including demographic, clinical, and study design characteristics, and within-study correlation was accounted for using generalised estimating equations.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Among 7353 participants (mean age 60 years, 48.0% female, 64.1% non-Hispanic (NH)-White, 17.8% NH-Black, 14.2% Hispanic), 1110 participants (15.1%, 95% CI 14.3\u201315.9%) discontinued study participation over a median 24-month follow-up. Multivariable analysis showed significantly higher risk of discontinuation among Hispanic (aOR 1.73, 95% CI 1.38\u20132.18) and NH-Black (aOR 1.36, 95% CI 1.14\u20131.62) participants, those with age &lt;50 years (aOR 1.46, 95% CI 1.21\u20131.77), 50\u201359 years (aOR 1.26, 95% CI 1.05\u20131.51), or \u226570 years (aOR 1.20, 95% CI 1.03\u20131.39), participants with higher baseline HbA1c (aOR 1.09 per unit increase, 95% CI 1.06\u20131.12), or baseline blood pressure \u2265140\/90\u2009mmHg (aOR 1.24, 95% CI 1.09\u20131.41), and those in studies with follow-up length 24 to &lt;36 months (aOR 1.64, 95% CI 1.02\u20132.64) or 36 to 48 months (aOR 2.68, 95% CI 1.87\u20133.84).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Approximately 15% of participants in the eligible DRCRnet studies discontinued participation. Racial and ethnic identity, age, glycaemic and blood pressure control, and study follow-up duration are significant predictors of participant discontinuation and should be considered when designing future studies.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1038\/s41433-026-04853-y","type":"journal-article","created":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T10:27:13Z","timestamp":1789122433000},"page":"2574-2580","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Incidence and baseline predictors of discontinuation in DRCRnet studies"],"prefix":"10.1038","volume":"40","author":[{"ORCID":"https:\/\/orcid.org\/0009-0006-7026-3705","authenticated-orcid":false,"given":"Klyve N.","family":"Otinkorang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"},{"role":"corresponding-author","vocabulary":"crossref"}]},{"given":"Gui-shuang","family":"Ying","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,9,11]]},"reference":[{"key":"4853_CR1","doi-asserted-by":"publisher","first-page":"489","DOI":"10.4239\/wjd.v6.i3.489","volume":"6","author":"MM Nentwich","year":"2015","unstructured":"Nentwich MM, Ulbig MW. Diabetic retinopathy\u2014ocular complications of diabetes mellitus. World J Diab. 2015;6:489\u201399. https:\/\/doi.org\/10.4239\/wjd.v6.i3.489.","journal-title":"World J Diab"},{"key":"4853_CR2","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.ajo.2019.10.012","volume":"210","author":"B Zhou","year":"2020","unstructured":"Zhou B, Mitchell TC, Rusakevich AM, Brown DM, Wykoff CC. Noncompliance in prospective retina clinical trials: analysis of factors predicting loss to follow-up. Am J Ophthalmol. 2020;210:86\u201396. https:\/\/doi.org\/10.1016\/j.ajo.2019.10.012.","journal-title":"Am J Ophthalmol"},{"key":"4853_CR3","doi-asserted-by":"publisher","first-page":"1386","DOI":"10.1016\/j.ophtha.2018.02.034","volume":"125","author":"A Obeid","year":"2018","unstructured":"Obeid A, Gao X, Ali FS, Talcott KE, Aderman CM, Hyman L, et al. Loss to follow-up in patients with proliferative diabetic retinopathy after panretinal photocoagulation or intravitreal anti-VEGF injections. Ophthalmology. 2018;125:1386\u201392. https:\/\/doi.org\/10.1016\/j.ophtha.2018.02.034.","journal-title":"Ophthalmology"},{"key":"4853_CR4","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1016\/j.oret.2024.04.016","volume":"8","author":"RN Khurana","year":"2024","unstructured":"Khurana RN, Wang JC, Zhang S, Li C, Lum F. Loss to follow up in patients with proliferative diabetic retinopathy treated with anti-VEGF therapy and\/or panretinal photocoagulation in the United States. Ophthalmol Retin. 2024;8:953\u201361. https:\/\/doi.org\/10.1016\/j.oret.2024.04.016.","journal-title":"Ophthalmol Retin"},{"key":"4853_CR5","doi-asserted-by":"publisher","first-page":"e2450942","DOI":"10.1001\/jamanetworkopen.2024.50942","volume":"7","author":"RS Huang","year":"2024","unstructured":"Huang RS, Naidu SC, Mihalache A, Popovic MM, Kertes PJ, Sarraf D, et al. Loss to follow-up in patients with proliferative diabetic retinopathy or diabetic macular edema. JAMA Netw Open. 2024;7:e2450942 https:\/\/doi.org\/10.1001\/jamanetworkopen.2024.50942.","journal-title":"JAMA Netw Open"},{"key":"4853_CR6","doi-asserted-by":"publisher","first-page":"2211","DOI":"10.2337\/dc19-0532","volume":"42","author":"Y Zhu","year":"2019","unstructured":"Zhu Y, Sidell MA, Arterburn D, Daley MF, Desai J, Fitzpatrick SL, et al. Racial\/ethnic disparities in the prevalence of diabetes and prediabetes by BMI: Patient outcomes research to advance learning (PORTAL) multisite cohort of adults in the U.S. Diab Care. 2019;42:2211\u20139. https:\/\/doi.org\/10.2337\/dc19-0532.","journal-title":"Diab Care"},{"key":"4853_CR7","doi-asserted-by":"publisher","first-page":"846","DOI":"10.3390\/healthcare12080846","volume":"12","author":"CM Hackl","year":"2024","unstructured":"Hackl CM, Lee WC, Sallam HS, Jneid H, Campbell KM, Serag H. Racial disparities in selected complications and comorbidities among people with type 2 diabetes. Healthcare. 2024;12:846 https:\/\/doi.org\/10.3390\/healthcare12080846.","journal-title":"Healthcare"},{"key":"4853_CR8","doi-asserted-by":"publisher","first-page":"034","DOI":"10.17352\/ijcem.000027","volume":"3","author":"A Barsegian","year":"2017","unstructured":"Barsegian A, Kotlyar B, Lee J, Salifu MO, McFarlane SI. Diabetic retinopathy: focus on minority populations. Int J Clin Endocrinol Metab. 2017;3:034\u201345. https:\/\/doi.org\/10.17352\/ijcem.000027.","journal-title":"Int J Clin Endocrinol Metab"},{"key":"4853_CR9","doi-asserted-by":"publisher","DOI":"10.1097\/IAE.0000000000004440","author":"JR Maturi","year":"2025","unstructured":"Maturi JR, Boucher N, Fernando R, Scott AW. Visual outcomes and adherence challenges in proliferative diabetic retinopathy anti-VEGF monotherapy in the clinical practice setting. Retin Philos Pa. 2025. https:\/\/doi.org\/10.1097\/IAE.0000000000004440.","journal-title":"Retin Philos Pa"},{"key":"4853_CR10","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-97644-2","volume":"11","author":"JS Kim","year":"2021","unstructured":"Kim JS, Lee S, Kim JY, Seo EJ, Chae JB, Kim DY. Visual\/anatomical outcome of diabetic macular edema patients lost to follow-up for more than 1 year. Sci Rep. 2021;11:18353. https:\/\/doi.org\/10.1038\/s41598-021-97644-2.","journal-title":"Sci Rep"},{"key":"4853_CR11","doi-asserted-by":"publisher","first-page":"1266","DOI":"10.1001\/jamaophthalmol.2021.4103","volume":"139","author":"MG Maguire","year":"2021","unstructured":"Maguire MG, Liu D, Bressler SB, Friedman SM, Melia M, Stockdale CR, et al. Lapses in care among patients assigned to ranibizumab for proliferative diabetic retinopathy: a post hoc analysis of a randomized clinical trial. JAMA Ophthalmol. 2021;139:1266\u201373. https:\/\/doi.org\/10.1001\/jamaophthalmol.2021.4103.","journal-title":"JAMA Ophthalmol"},{"key":"4853_CR12","doi-asserted-by":"publisher","unstructured":"Chalasani M, Maatouk C, Markle J, Singh RP, Talcott KE. Predictors of vision loss after lapse in antivascular endothelial growth factor treatment in patients with diabetic macular edema. J Vitreoretin Dis. 2024;24741264241305123. https:\/\/doi.org\/10.1177\/24741264241305123 PubMed.","DOI":"10.1177\/24741264241305123"},{"key":"4853_CR13","doi-asserted-by":"publisher","unstructured":"Zhu G, Westlund E, Tran D, Cai CX. The association of lapses in diabetic retinopathy care with vision impairment. Ophthalmol Sci. 2025;0. https:\/\/doi.org\/10.1016\/j.xops.2025.100958","DOI":"10.1016\/j.xops.2025.100958"},{"key":"4853_CR14","doi-asserted-by":"publisher","unstructured":"Applebaum SS, Deng Y, Fu JJ, Kane M, Nwanyanwu KH, Sight Outcomes Research Collaborative (SOURCE) Consortium. Risk Factors and Consequences of Lapses in Proliferative Diabetic Retinopathy Care in a National Cohort. Diabetes Care. 2025;dc251202. https:\/\/doi.org\/10.2337\/dc25-1202 PubMed PMID: 40956999.","DOI":"10.2337\/dc25-1202"},{"key":"4853_CR15","doi-asserted-by":"publisher","unstructured":"Spanakis EK, Golden SH. Race\/Ethnic Difference in Diabetes and Diabetic Complications. Curr Diab Rep. 2013;13:. https:\/\/doi.org\/10.1007\/s11892-013-0421-9.","DOI":"10.1007\/s11892-013-0421-9"},{"key":"4853_CR16","doi-asserted-by":"publisher","first-page":"E1579","DOI":"10.1210\/jc.2012-2043","volume":"97","author":"SH Golden","year":"2012","unstructured":"Golden SH, Brown A, Cauley JA, Chin MH, Gary-Webb TL, Kim C, et al. Health disparities in endocrine disorders: biological, clinical, and nonclinical factors-an Endocrine Society scientific statement. J Clin Endocrinol Metab. 2012;97:E1579\u20131639. https:\/\/doi.org\/10.1210\/jc.2012-2043.","journal-title":"J Clin Endocrinol Metab"},{"key":"4853_CR17","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.ajo.2020.03.011","volume":"215","author":"R Suresh","year":"2020","unstructured":"Suresh R, Yu HJ, Thoveson A, Swisher J, Apolinario M, Zhou B, et al. Loss to follow-up among patients with proliferative diabetic retinopathy in clinical practice. Am J Ophthalmol. 2020;215:66\u201371. https:\/\/doi.org\/10.1016\/j.ajo.2020.03.011.","journal-title":"Am J Ophthalmol"},{"key":"4853_CR18","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.ajo.2020.03.023","volume":"216","author":"M Green","year":"2020","unstructured":"Green M, Tien T, Ness S. Predictors of lost to follow-up in patients being treated for proliferative diabetic retinopathy. Am J Ophthalmol. 2020;216:18\u201327. https:\/\/doi.org\/10.1016\/j.ajo.2020.03.023.","journal-title":"Am J Ophthalmol"},{"key":"4853_CR19","doi-asserted-by":"publisher","first-page":"e89","DOI":"10.1016\/j.ophtha.2022.07.010","volume":"129","author":"AR Elam","year":"2022","unstructured":"Elam AR, Tseng VL, Rodriguez TM, Mike EV, Warren AK, Coleman AL, et al. Disparities in vision health and eye care. Ophthalmology. 2022;129:e89\u2013113. https:\/\/doi.org\/10.1016\/j.ophtha.2022.07.010.","journal-title":"Ophthalmology"},{"key":"4853_CR20","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1097\/IAE.0000000000003911","volume":"44","author":"T Bowe","year":"2024","unstructured":"Bowe T, Mahmoudzadeh R, Soares RR, Nguyen MK, Hsu J, Kuriyan AE. Characteristics of participants in diabetic retinopathy clinical research clinical trials who were lost to follow-up. RETINA. 2024;44:111 https:\/\/doi.org\/10.1097\/IAE.0000000000003911.","journal-title":"RETINA"},{"key":"4853_CR21","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1055\/s-0030-1267080","volume":"2","author":"JR Dettori","year":"2011","unstructured":"Dettori JR. Loss to follow-up. Evid-Based Spine-Care J. 2011;2:7\u201310. https:\/\/doi.org\/10.1055\/s-0030-1267080.","journal-title":"Evid-Based Spine-Care J"},{"key":"4853_CR22","unstructured":"DRCR Retina Network\u2014Public Site [Internet]. [cited 2025 Aug 4]. Available from: https:\/\/public.jaeb.org\/drcrnet\/view\/General_Info."},{"key":"4853_CR23","doi-asserted-by":"publisher","unstructured":"Sun JK, Jampol LM. The Diabetic Retinopathy Clinical Research Network (DRCR.net) and Its Contributions to the Treatment of Diabetic Retinopathy [Internet]. [cited 2025 Aug 5]. Available from: https:\/\/doi.org\/10.1159\/000502779","DOI":"10.1159\/000502779"},{"key":"4853_CR24","doi-asserted-by":"publisher","first-page":"1547","DOI":"10.1002\/cncr.34701","volume":"129","author":"V Puthenpura","year":"2023","unstructured":"Puthenpura V, Ji L, Xu X, Roth ME, Freyer DR, Frazier AL, et al. Loss to follow-up of minorities, adolescents, and young adults on clinical trials: a report from the Children\u2019s Oncology Group. Cancer. 2023;129:1547\u201356. https:\/\/doi.org\/10.1002\/cncr.34701.","journal-title":"Cancer"},{"key":"4853_CR25","doi-asserted-by":"publisher","DOI":"10.1016\/j.socscimed.2020.113009","volume":"255","author":"I Mindlis","year":"2020","unstructured":"Mindlis I, Livert D, Federman AD, Wisnivesky JP, Revenson TA. Racial\/ethnic concordance between patients and researchers as a predictor of study attrition. Soc Sci Med. 2020;255:113009. https:\/\/doi.org\/10.1016\/j.socscimed.2020.113009.","journal-title":"Soc Sci Med"},{"key":"4853_CR26","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1016\/j.cct.2010.06.006","volume":"31","author":"AT Langford","year":"2010","unstructured":"Langford AT, Resnicow K, Davis RE, Alexander G, Calvi J, Weise C, et al. Ethnic identity predicts loss-to-follow-up in a health promotion trial. Contemp Clin Trials. 2010;31:414\u20138. https:\/\/doi.org\/10.1016\/j.cct.2010.06.006.","journal-title":"Contemp Clin Trials"},{"key":"4853_CR27","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1007\/s00417-021-05246-5","volume":"260","author":"TR Rosenblatt","year":"2022","unstructured":"Rosenblatt TR, Rayess N, Al-Moujahed A, Khurana RN, Mruthyunjaya P. Discontinuation and loss to follow-up rates in clinical trials of intravitreal anti-vascular endothelial growth factor injections. Graefes Arch Clin Exp Ophthalmol. 2022;260:93\u2013100. https:\/\/doi.org\/10.1007\/s00417-021-05246-5.","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"4853_CR28","unstructured":"CRAN: Package eye [Internet]. [cited 2025 Jun 26]. Available from: https:\/\/cran.r-project.org\/web\/packages\/eye\/index.html."},{"key":"4853_CR29","doi-asserted-by":"publisher","first-page":"888","DOI":"10.1001\/jamaophthalmol.2015.1312","volume":"133","author":"Cluster Randomized Trial","year":"2015","unstructured":"Cluster Randomized TrialAssessing the effect on diabetes control of personalized diabetes complication risk assessment during ophthalmology exams. JAMA Ophthalmol. 2015;133:888\u201396. https:\/\/doi.org\/10.1001\/jamaophthalmol.2015.1312.","journal-title":"JAMA Ophthalmol"},{"key":"4853_CR30","doi-asserted-by":"publisher","first-page":"872","DOI":"10.1001\/archophthalmol.2011.163","volume":"129","author":"Y Murakami","year":"2011","unstructured":"Murakami Y, Lee BW, Duncan M, Kao A, Huang JY, Singh K, et al. Racial and ethnic disparities in adherence to glaucoma follow-up visits in a county hospital population. Arch Ophthalmol. 2011;129:872\u20138. https:\/\/doi.org\/10.1001\/archophthalmol.2011.163.","journal-title":"Arch Ophthalmol"},{"key":"4853_CR31","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1016\/j.ophtha.2023.02.021","volume":"130","author":"RN Khurana","year":"2023","unstructured":"Khurana RN, Li C, Lum F. Loss to follow-up in patients with neovascular age-related macular degeneration treated with anti\u2013VEGF therapy in the United States in the IRIS\u00ae registry. Ophthalmology. 2023;130:672\u201383. https:\/\/doi.org\/10.1016\/j.ophtha.2023.02.021.","journal-title":"Ophthalmology"},{"key":"4853_CR32","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.119.015361","volume":"9","author":"LCW Fong","year":"2020","unstructured":"Fong LCW, Ford TJ, da Costa BR, J\u00fcni P, Berry C. Bias and loss to follow-up in cardiovascular randomized trials: a systematic review. J Am Heart Assoc. 2020;9:e015361. https:\/\/doi.org\/10.1161\/JAHA.119.015361.","journal-title":"J Am Heart Assoc"},{"key":"4853_CR33","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/j.ajo.2025.02.029","volume":"273","author":"M Li","year":"2025","unstructured":"Li M, He J, Vanderbeek BL, Ying GS. Racial and ethnic disparities at enrollment in DRCRnet clinical trials for diabetic macular edema. Am J Ophthalmol. 2025;273:231\u20139. https:\/\/doi.org\/10.1016\/j.ajo.2025.02.029.","journal-title":"Am J Ophthalmol"},{"key":"4853_CR34","doi-asserted-by":"publisher","DOI":"10.1016\/j.xops.2023.100402","volume":"4","author":"F Montazeri","year":"2024","unstructured":"Montazeri F, Wang M, Atkuru A, Estrada MM, Liu YA, Emami-Naeini P. Racial, ethnic, and gender diversity in United States ophthalmology clinical trials. Ophthalmol Sci. 2024;4:100402. https:\/\/doi.org\/10.1016\/j.xops.2023.100402.","journal-title":"Ophthalmol Sci"},{"key":"4853_CR35","doi-asserted-by":"publisher","first-page":"16","DOI":"10.3390\/jcto3030016","volume":"3","author":"A Shafiee","year":"2025","unstructured":"Shafiee A, Juran T, Zabaneh I, Patel D, Allison K. Racial and gender disparities in clinical trial representation for age-related macular degeneration treatments: a scoping review. J Clin Transl Ophthalmol. 2025;3:16 https:\/\/doi.org\/10.3390\/jcto3030016.","journal-title":"J Clin Transl Ophthalmol"},{"key":"4853_CR36","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/S0027-9684(15)30833-6","volume":"101","author":"RV Katz","year":"2009","unstructured":"Katz RV, Green BL, Kressin NR, James SA, Wang MQ, Claudio C, et al. Exploring the \u201cLegacy\u201d of the Tuskegee syphilis study: a follow-up study from the Tuskegee legacy project. J Natl Med Assoc. 2009;101:179\u201383. https:\/\/doi.org\/10.1016\/S0027-9684(15)30833-6.","journal-title":"J Natl Med Assoc"},{"key":"4853_CR37","doi-asserted-by":"publisher","DOI":"10.1017\/cts.2023.559","volume":"7","author":"SP Fisher-Hoch","year":"2023","unstructured":"Fisher-Hoch SP, Below JE, North KE, McCormick JB. Challenges and strategies for recruitment of minorities to clinical research and trials. J Clin Transl Sci. 2023;7:e154. https:\/\/doi.org\/10.1017\/cts.2023.559.","journal-title":"J Clin Transl Sci"},{"key":"4853_CR38","doi-asserted-by":"publisher","first-page":"e26","DOI":"10.1164\/rccm.202105-1210ST","volume":"204","author":"N Thakur","year":"2021","unstructured":"Thakur N, Lovinsky-Desir S, Appell D, Bime C, Castro L, Celed\u00f3n JC, et al. Enhancing recruitment and retention of minority populations for clinical research in pulmonary, critical care, and sleep medicine: an Official American Thoracic Society Research Statement. Am J Respir Crit Care Med. 2021;204:e26\u201350. https:\/\/doi.org\/10.1164\/rccm.202105-1210ST.","journal-title":"Am J Respir Crit Care Med"},{"key":"4853_CR39","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/j.apnr.2014.02.007","volume":"27","author":"MC McCullagh","year":"2014","unstructured":"McCullagh MC, Sanon MA, Cohen MA. Strategies to enhance participant recruitment and retention in research involving a community-based population. Appl Nurs Res. 2014;27:249\u201353. https:\/\/doi.org\/10.1016\/j.apnr.2014.02.007.","journal-title":"Appl Nurs Res"},{"key":"4853_CR40","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1016\/j.mayocp.2020.03.028","volume":"96","author":"ML Wieland","year":"2021","unstructured":"Wieland ML, Njeru JW, Alahdab F, Doubeni CA, Sia IG. Community-engaged approaches for minority recruitment into clinical research: a scoping review of the literature. Mayo Clin Proc. 2021;96:733\u201343. https:\/\/doi.org\/10.1016\/j.mayocp.2020.03.028.","journal-title":"Mayo Clin Proc"},{"key":"4853_CR41","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1016\/j.outlook.2004.04.012","volume":"52","author":"BL Dancy","year":"2004","unstructured":"Dancy BL, Wilbur J, Talashek M, Bonner G, Barnes-Boyd C. Community-based research: barriers to recruitment of African Americans. Nurs Outlook. 2004;52:234\u201340. https:\/\/doi.org\/10.1016\/j.outlook.2004.04.012.","journal-title":"Nurs Outlook"},{"key":"4853_CR42","doi-asserted-by":"publisher","first-page":"3","DOI":"10.4103\/picr.picr_161_21","volume":"14","author":"S Poongothai","year":"2023","unstructured":"Poongothai S, Anjana RM, Aarthy R, Unnikrishnan R, Venkat Narayan KM, Ali MK, et al. Strategies for participant retention in long term clinical trials: A participant \u2013centric approaches. Perspect Clin Res. 2023;14:3\u20139. https:\/\/doi.org\/10.4103\/picr.picr_161_21.","journal-title":"Perspect Clin Res"},{"key":"4853_CR43","doi-asserted-by":"publisher","first-page":"2955","DOI":"10.1111\/jgs.16875","volume":"68","author":"ND Forsat","year":"2020","unstructured":"Forsat ND, Palmowski A, Palmowski Y, Boers M, Buttgereit F. Recruitment and retention of older people in clinical research: a systematic literature review. J Am Geriatr Soc. 2020;68:2955\u201363. https:\/\/doi.org\/10.1111\/jgs.16875.","journal-title":"J Am Geriatr Soc"},{"key":"4853_CR44","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1177\/0164027512453468","volume":"35","author":"CS Marcum","year":"2013","unstructured":"Marcum CS. Age differences in daily social activities. Res Aging. 2013;35:612\u201340. https:\/\/doi.org\/10.1177\/0164027512453468.","journal-title":"Res Aging"},{"key":"4853_CR45","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1183\/09031936.00059814","volume":"44","author":"MJ Divo","year":"2014","unstructured":"Divo MJ, Martinez CH, Mannino DM. Ageing and the epidemiology of multimorbidity. Eur Respir J. 2014;44:1055\u201368. https:\/\/doi.org\/10.1183\/09031936.00059814.","journal-title":"Eur Respir J"},{"key":"4853_CR46","unstructured":"National Academies of Sciences E, Education D of B and SS and, Division H and M, Board on Behavioral C, Policy B on HS, Adults C on the H and MD of SI and L in O. Risk and Protective Factors for Social Isolation and Loneliness. In: Social Isolation and Loneliness in Older Adults: Opportunities for the Health Care System [Internet]. National Academies Press (US); 2020 [cited 2025 Jun 30]. Available from: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK557971\/."},{"key":"4853_CR47","doi-asserted-by":"publisher","first-page":"e0229665","DOI":"10.1371\/journal.pone.0229665","volume":"15","author":"L Liu","year":"2020","unstructured":"Liu L, Quang ND, Banu R, Kumar H, Tham YC, Cheng CY, et al. Hypertension, blood pressure control and diabetic retinopathy in a large population-based study. PLoS One. 2020;15:e0229665. https:\/\/doi.org\/10.1371\/journal.pone.0229665.","journal-title":"PLoS One"},{"key":"4853_CR48","doi-asserted-by":"publisher","first-page":"497","DOI":"10.2337\/db23-497-P","volume":"72","author":"N NAM NGUYEN","year":"2023","unstructured":"NAM NGUYEN N, THY KHUE N. 497-P: Hypertension aggravated the risk of diabetic retinopathy over 10 years. Diabetes. 2023;72:497\u2013P. https:\/\/doi.org\/10.2337\/db23-497-P.","journal-title":"Diabetes"},{"key":"4853_CR49","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD006127.pub3","volume":"3","author":"DV Do","year":"2023","unstructured":"Do DV, Han G, Abariga SA, Sleilati G, Vedula SS, Hawkins BS. Blood pressure control for diabetic retinopathy. Cochrane Database Syst Rev. 2023;3:CD006127. https:\/\/doi.org\/10.1002\/14651858.CD006127.pub3.","journal-title":"Cochrane Database Syst Rev"},{"key":"4853_CR50","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.12520","volume":"13","author":"NM Almutairi","year":"2021","unstructured":"Almutairi NM, Alahmadi S, Alharbi M, Gotah S, Alharbi M. The Association between HbA1c and other biomarkers with the prevalence and severity of diabetic retinopathy. Cureus. 2021;13:e12520. https:\/\/doi.org\/10.7759\/cureus.12520.","journal-title":"Cureus"},{"key":"4853_CR51","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1007\/s11606-010-1253-9","volume":"25","author":"MA Fischer","year":"2010","unstructured":"Fischer MA, Stedman MR, Lii J, Vogeli C, Shrank WH, Brookhart MA, et al. Primary medication non-adherence: analysis of 195,930 electronic prescriptions. J Gen Intern Med. 2010;25:284\u201390. https:\/\/doi.org\/10.1007\/s11606-010-1253-9.","journal-title":"J Gen Intern Med"},{"key":"4853_CR52","doi-asserted-by":"publisher","first-page":"2443","DOI":"10.2147\/OPTH.S114006","volume":"10","author":"S Kiss","year":"2016","unstructured":"Kiss S, Chandwani HS, Cole AL, Patel VD, Lunacsek OE, Dugel PU. Comorbidity and health care visit burden in working-age commercially insured patients with diabetic macular edema. Clin Ophthalmol. 2016;10:2443\u201353. https:\/\/doi.org\/10.2147\/OPTH.S114006.","journal-title":"Clin Ophthalmol"},{"key":"4853_CR53","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1900\/RDS.2013.10.121","volume":"10","author":"YC Chang","year":"2013","unstructured":"Chang YC, Wu WC. Dyslipidemia and diabetic retinopathy. Rev Diabet Stud Rds. 2013;10:121\u201332. https:\/\/doi.org\/10.1900\/RDS.2013.10.121.","journal-title":"Rev Diabet Stud Rds"}],"container-title":["Eye"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41433-026-04853-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41433-026-04853-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41433-026-04853-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T16:09:05Z","timestamp":1794413345000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41433-026-04853-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,11]]},"references-count":53,"journal-issue":{"issue":"16","published-print":{"date-parts":[[2026,11]]}},"alternative-id":["4853"],"URL":"https:\/\/doi.org\/10.1038\/s41433-026-04853-y","relation":{},"ISSN":["0950-222X","1476-5454"],"issn-type":[{"value":"0950-222X","type":"print"},{"value":"1476-5454","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,11]]},"assertion":[{"value":"17 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 July 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 September 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 September 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}]}}